In conclusion, the present study demonstrated that Lobetyolin exhibited anti‐cancer effect on colon cancer HCT‐116 cells through the apoptosis regulated by ASCT2‐modulated glutamine metabolism, which was governed by p53. This evidence concerns the gene TP53 and cancer.